|
Status |
Public on Jul 30, 2021 |
Title |
A BRD4-mediated elongation control point primes transcribing RNA polymerase II for 3'-processing and termination [NET-seq] |
Organism |
Homo sapiens |
Experiment type |
Other
|
Summary |
In this study, we reveal that BRD4 underlies a general 5'-elongation checkpoint that primes transcribing RNA polymerase II for 3'-RNA processing and transcription termination. BRD4-specific degradation impairs Pol II pause release, induces massive readthrough transcription, and RNA cleavage defects. Acute loss of BRD4 disrupts the recruitment of 3'-RNA processing factors.
|
|
|
Overall design |
SI-NET-seq measurements for indicated time points upon DMSO (control), dTAG7 (BRD4 degradation) and dBET6 (pan-BET degradation) treatment in MOLT4 and K562 dTAG-BRD4 cells (two biological replicate measurements for each condition).
|
|
|
Contributor(s) |
Arnold M, Bressin A, Jasnovidova O, Meierhofer D, Mayer A |
Citation(s) |
34324863 |
|
Submission date |
Oct 02, 2020 |
Last update date |
Jul 31, 2021 |
Contact name |
Dr. Andreas Mayer |
Organization name |
Max-Plack-Institute for molecular genetics
|
Street address |
Ihnestraße 63-73
|
City |
Berlin |
ZIP/Postal code |
14195 |
Country |
Germany |
|
|
Platforms (3) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (18)
|
|
This SubSeries is part of SuperSeries: |
GSE158966 |
A BRD4-mediated elongation control point primes transcribing RNA polymerase II for 3'-processing and termination |
|
Relations |
BioProject |
PRJNA667099 |
SRA |
SRP286218 |